NO donors-relaxation is impaired in aorta from hypertensive rats due to a reduced involvement of K + channels and sarcoplasmic reticulum Ca 2+-ATPase

Life Sciences

Volumn 89, Issue 17-18, 2011, Pages 595-602

  Bonaventura, Daniella ^a   De Lima, Renata Galvão ^b   Da Silva, Roberto Santana ^c   Bendhack, Lusiane Maria ^c  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

K + channel; Nitric oxide donor; Renal hypertension

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; CYCLIC GMP; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; POTASSIUM CHANNEL; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; TETRYLAMMONIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; HYPERTENSION; MALE; NONHUMAN; RAT; VASCULAR RING; VASODILATATION;

ANIMALS; AORTA; CYCLIC GMP; GUANYLATE CYCLASE; HYPERTENSION; HYPERTENSION, RENAL; MALE; NITRIC OXIDE DONORS; NITROPRUSSIDE; ORGANOMETALLIC COMPOUNDS; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RATS; RATS, WISTAR; RUTHENIUM; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; VASODILATION;

RATTUS;

EID: 80053561003     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2011.07.022     Document Type: Article

References (55)

1. M. Ajay, F.I. Achike, and M.R. Mustafa Modulation of vascular reactivity in normal, hypertensive and diabetic rat aortae by a non-antioxidant flavonoid Pharmacol Res 55 5 2007 385 391 (Pubitemid 46560390)
2. J.A. Angus, A.C. Dyke, G.L. Jennings, P.I. Korner, K. Sudhir, and J.E. Ward Release of endothelium-derived relaxing factor from resistance arteries in hypertension Kidney Int Suppl 37 1992 S73 S78
3. S.L. Archer, J.M. Huang, V. Hampl, D.P. Nelson, P.J. Shultz, and E.K. Weir Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase Proc Natl Acad Sci U S A 91 16 1994 7583 7587 (Pubitemid 24238229)
4. E.H. Bae, S.K. Ma, J. Lee, and S.W. Kim Altered regulation of renal nitric oxide and atrial natriuretic peptide systems in angiotensin II-induced hypertension Regul Pept 170 1-3 2011 31 37
5. J.A. Bauer, T. Nolan, and H.L. Fung Vascular and hemodynamic differences between organic nitrates and nitrites J Pharmacol Exp Ther 280 1 1997 326 331 (Pubitemid 27171419)
6. V.M. Bolotina, S. Najibi, J.J. Palacino, P.J. Pagano, and R.A. Cohen Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle Nature 368 6474 1994 850 853 (Pubitemid 24137748)
7. D. Bonaventura, F.S. de Oliveira, V. Togniolo, A.C. Tedesco, R.S. da Silva, and L.M. Bendhack A macrocyclic nitrosyl ruthenium complex is a NO donor that induces rat aorta relaxation Nitric Oxide 10 2 2004 83 91 (Pubitemid 38591617)
8. D. Bonaventura, F.S. Oliveira, R.S. da Silva, and L.M. Bendhack Decreased vasodilation induced by a new nitric oxide donor in two kidney, one clip hypertensive rats is due to impaired K+ channel activation Clin Exp Pharmacol Physiol 32 5-6 2005 478 481 (Pubitemid 40780279)
9. D. Bonaventura, F.S. Oliveira, C.N. Lunardi, J.A. Vercesi, R.S. da Silva, and L.M. Bendhack Characterization of the mechanisms of action and nitric oxide species involved in the relaxation induced by the ruthenium complex Nitric Oxide Biol Chem 15 4 2006 387 394 (Pubitemid 44647894)
10. D. Bonaventura, R.G. de Lima, J.A. Vercesi, R.S. da Silva, and L.M. Bendhack Comparison of the mechanisms underlying the relaxation induced by two nitric oxide donors: sodium nitroprusside and a new ruthenium complex Vascul Pharmacol 46 3 2007 215 222 (Pubitemid 46096814)
11. A.C. Borges, T. Feres, L.M. Vianna, and T.B. Paiva Recovery of impaired K+ channels in mesenteric arteries from spontaneously hypertensive rats by prolonged treatment with cholecalciferol Br J Pharmacol 127 3 1999 772 778 (Pubitemid 29276663)
12. G.E. Callera, W.A. Varanda, and L.M. Bendhack Impaired relaxation to acetylcholine in 2K-1C hypertensive rat aortas involves changes in membrane hyperpolarization instead of an abnormal contribution of endothelial factors Gen Pharmacol 34 6 2000 379 389 (Pubitemid 32718753)
13. G.E. Callera, A. Yogi, R.C. Tostes, L.V. Rossoni, and L.M. Bendhack Ca2+-activated K+ channels underlying the impaired acetylcholine-induced vasodilation in 2K-1C hypertensive rats J Pharmacol Exp Ther 309 3 2004 1036 1042 (Pubitemid 38669689)
14. A.L. Cogolludo, F. Perez-Vizcaino, S. Fajardo, M. Ibarra, and J. Tamargo Effects of nicorandil as compared to mixtures of sodium nitroprusside and levcromakalim in isolated rat aorta Br J Pharmacol 126 4 1999 1025 1033 (Pubitemid 29103720)
15. R.H. Cox Changes in the expression and function of arterial potassium channels during hypertension Vascul Pharmacol 38 1 2002 13 23 (Pubitemid 36398286)
16. R. Dubin, C. Owens, W. Gasper, P. Ganz, and K. Johansen Associations of endothelial dysfunction and arterial stiffness with intradialytic hypotension and hypertension Hemodial Int 15 3 2011 350 358
17. M. Feelisch Biotransformation to nitric oxide of organic nitrates in comparison to other nitrovasodilators Eur Heart J 14 Suppl. I 1993 123 132 (Pubitemid 23362605)
18. M. Feelisch, and E.A. Noack Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase Eur J Pharmacol 139 1 1987 19 30 (Pubitemid 17093700)
19. M. Feelisch, P. Kotsonis, J. Siebe, B. Clement, and H.H. Schmidt The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation Mol Pharmacol 56 2 1999 243 253 (Pubitemid 29347599)
20. H. Goldblatt, J. Lynch, R.F. Hanzal, and W.W. Summerville Studies on experimental hypertension: I. The production of persistent elevation of systolic blood pressure by means of renal ischemia J Exp Med 59 3 1934 347 379
21. Y. Hirooka, T. Kishi, K. Sakai, A. Takeshita, and K. Sunagawa Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension Am J Physiol Regul Integr Comp Physiol 300 4 2011 R818 R826
22. A.J. Hobbs Soluble guanylate cyclase: the forgotten sibling Trends Pharmacol Sci 18 12 1997 484 491
23. K.L. Homer, S.A. Fiore, and J.C. Wanstall Inhibition by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) of responses to nitric oxide-donors in rat pulmonary artery: influence of the mechanism of nitric oxide generation J Pharm Pharmacol 51 2 1999 135 139 (Pubitemid 29131305)
24. J.C. Irvine, J.L. Favaloro, and B.K. Kemp-Harper NO- activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteries Hypertension 41 6 2003 1301 1307 (Pubitemid 36706081)
25. Y. Ishibashi, D.J. Duncker, J. Zhang, and R.J. Bache ATP-sensitive K+ channels, adenosine, and nitric oxide-mediated mechanisms account for coronary vasodilation during exercise Circ Res 82 3 1998 346 359 (Pubitemid 28101192)
26. J. Keeble, O.A. Al-Swayeh, and P.K. Moore Vasorelaxant effect of nitric oxide releasing steroidal and nonsteroidal anti-inflammatory drugs Br J Pharmacol 133 7 2001 1023 1028 (Pubitemid 32762411)
27. I. Lobysheva, G. Rath, B. Sekkali, C. Bouzin, O. Feron, and B. Gallez Moderate caveolin-1 downregulation prevents NADPH oxidase-dependent endothelial nitric oxide synthase uncoupling by angiotensin II in endothelial cells Arterioscler Thromb Vasc Biol 2011 Jun 9. [Epub ahead of print]
28. E. Martin, K. Davis, K. Bian, Y.C. Lee, and F. Murad Cellular signaling with nitric oxide and cyclic guanosine monophosphate Semin Perinatol 24 1 2000 2 6 (Pubitemid 30115261)
29. D.L. Michell, K.L. Andrews, and J.P. Chin-Dusting Endothelial dysfunction in hypertension: the role of arginase Front Biosci (Schol Ed) 3 2011 946 960
30. D.K. Mistry, and C.J. Garland Nitric oxide (NO)-induced activation of large conductance Ca2+-dependent K+ channels (BK (Ca)) in smooth muscle cells isolated from the rat mesenteric artery Br J Pharmacol 124 6 1998 1131 1140 (Pubitemid 28333935)
31. S. Moncada, R.M. Palmer, and E.A. Higgs Nitric oxide: physiology, pathophysiology, and pharmacology Pharmacol Rev 43 2 1991 109 142
32. P.S. Munk, N. Butt, and A.I. Larsen Endothelial dysfunction predicts clinical restenosis after percutaneous coronary intervention Scand Cardiovasc J 45 3 2011 139 145
33. F. Murad The nitric oxide-cyclic GMP signal transduction system for intracellular and intercellular communication Recent Prog Horm Res 49 1994 239 248 (Pubitemid 24976630)
34. A.P. Oliveira, C.N. Lunardi, G.J. Rodrigues, and L.M. Bendhack Relaxation induced by calcium ionophore is impaired in carotid arteries from 2K-1C rats due to failed effect of nitric oxide on the smooth muscle cells Vascul Pharmacol 50 5-6 2009 153 159
35. W. Peng, J.R. Hoidal, and I.S. Farrukh Regulation of Ca(2+)-activated K+ channels in pulmonary vascular smooth muscle cells: role of nitric oxide J Appl Physiol 81 3 1996 1264 1272 (Pubitemid 26309136)
36. P. Puddu, G.M. Puddu, F. Zaca, and A. Muscari Endothelial dysfunction in hypertension Acta Cardiol 55 4 2000 221 232
37. P. Rauhala, A. Khaldi, K.P. Mohanakumar, and C.C. Chiueh Apparent role of hydroxyl radicals in oxidative brain injury induced by sodium nitroprusside Free Radic Biol Med 24 7-8 1998 1065 1073 (Pubitemid 28246719)
38. B.E. Robertson, R. Schubert, J. Hescheler, and M.T. Nelson cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells Am J Physiol 265 1 Pt 1 1993 C299 C303
39. G.J. Rodrigues, C.N. Lunardi, R.G. Lima, C.X. Santos, F.R. Laurindo, and R.S. da Silva Vitamin C improves the effect of a new nitric oxide donor on the vascular smooth muscle from renal hypertensive rats Nitric Oxide 18 3 2008 176 183
40. M. Romero, R. Jimenez, B. Hurtado, J.M. Moreno, I. Rodriguez-Gomez, and R. Lopez-Sepulveda Lack of beneficial metabolic effects of quercetin in adult spontaneously hypertensive rats Eur J Pharmacol 627 1-3 2009 242 250
41. K. Sathishkumar, R.G. Ross, D.U. Bawankule, K.K. Sardar, V.R. Prakash, and S.K. Mishra Segmental heterogeneity in the mechanism of sodium nitroprusside-induced relaxation in ovine pulmonary artery J Cardiovasc Pharmacol 45 6 2005 491 498 (Pubitemid 40734568)
42. E.L. Schiffrin A critical review of the role of endothelial factors in the pathogenesis of hypertension J Cardiovasc Pharmacol 38 Suppl. 2 2001 S3 S6
43. A.P. Sendao Oliveira, and L.M. Bendhack Relaxation induced by acetylcholine involves endothelium-derived hyperpolarizing factor in 2-kidney 1-clip hypertensive rat carotid arteries Pharmacology 72 4 2004 231 239 (Pubitemid 39482692)
44. C.G. Sobey Potassium channel function in vascular disease Arterioscler Thromb Vasc Biol 21 1 2001 28 38 (Pubitemid 32061924)
45. A. Soloviev, V. Lehen'kyi, S. Zelensky, and P. Hellstrand Nitric oxide relaxes rat tail artery smooth muscle by cyclic GMP-independent decrease in calcium sensitivity of myofilaments Cell Calcium 36 2 2004 165 173 (Pubitemid 38950067)
46. E. Stankevicius, A.C. Martinez, M.J. Mulvany, and U. Simonsen Blunted acetylcholine relaxation and nitric oxide release in arteries from renal hypertensive rats J Hypertens 20 8 2002 1571 1579 (Pubitemid 34921181)
47. S. Taddei, A. Virdis, L. Ghiadoni, and A. Salvetti Endothelial dysfunction in hypertension: fact or fancy? J Cardiovasc Pharmacol 32 Suppl. 3 1998 S41 S47
48. M. Tare, H.C. Parkington, H.A. Coleman, T.O. Neild, and G.J. Dusting Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from the endothelium Nature 346 6279 1990 69 71
49. C.M. Tseng, M.A. Tabrizi-Fard, and H.L. Fung Differential sensitivity among nitric oxide donors toward ODQ-mediated inhibition of vascular relaxation J Pharmacol Exp Ther 292 2 2000 737 742 (Pubitemid 30067439)
50. C. van Breemen, P. Skarsgard, I. Laher, B. McManus, and X. Wang Endothelium-smooth muscle interactions in blood vessels Clin Exp Pharmacol Physiol 24 12 1997 989 992 (Pubitemid 27494316)
51. G.W. Vega, M.I. Roson, A. Bellver, M.M. Celentano, and I.J. de la Riva Nitric oxide and superoxide anions in vascular reactivity of renovascular hypertensive rats Clin Exp Hypertens 17 5 1995 817 835
52. U. Walter Physiological role of cGMP and cGMP-dependent protein kinase in the cardiovascular system Rev Physiol Biochem Pharmacol 113 1989 41 88
53. D.A. Wink, K.S. Kasprzak, C.M. Maragos, R.K. Elespuru, M. Misra, and T.M. Dunams DNA deaminating ability and genotoxicity of nitric oxide and its progenitors Science 254 5034 1991 1001 1003 (Pubitemid 21917428)
54. K. Yunoki, K. Nakamura, T. Miyoshi, K. Enko, M. Kubo, and M. Murakami Impact of hypertriglyceridemia on endothelial dysfunction during statin +/- ezetimibe therapy in patients with coronary heart disease Am J Cardiol 108 3 2011 333 339
55. Y. Zhao, P.E. Brandish, M. DiValentin, J.P. Schelvis, G.T. Babcock, and M.A. Marletta Inhibition of soluble guanylate cyclase by ODQ Biochemistry 39 35 2000 10848 10854